Total pharmaceutical consumption | A-Alimentary tract and metabolism | Defined daily dosage per 1 000 inhabitants per day | | | | | | | | | |
A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) | | | | | | | | | |
A10-Drugs used in diabetes | | | | | | | | | |
B-Blood and blood forming organs | | | | | | | | | |
C-Cardiovascular system | | | | | | | | | |
C01A-Cardiac glycosides | | | | | | | | | |
C01B-Antiarrhythmics, Class I and III | | | | | | | | | |
C02-Antihypertensives | | | | | | | | | |
C03-Diuretics | | | | | | | | | |
C07-Beta blocking agents | | | | | | | | | |
C08-Calcium channel blockers | | | | | | | | | |
C09-Agents acting on the Renin-Angiotensin system | | | | | | | | | |
C10-Lipid modifying agents | | | | | | | | | |
G-Genito urinary system and sex hormones | | | | | | | | | |
G03-Sex hormones and modulators of the genital system | | | | | | | | | |
H-Systemic hormonal preparations, excluding sex hormones and insulins | | | | | | | | | |
J-Antiinfectives for systemic use | | | | | | | | | |
J01-Antibacterials for systemic use | | | | | | | | | |
M-Musculo-skeletal system | | | | | | | | | |
M01A-Antiinflammatory and antirheumatic products non-steroids | | | | | | | | | |
N-Nervous system | | | | | | | | | |
N02-Analgesics | | | | | | | | 16 | |
N05B-Anxiolytics | | | | | | | | 6.7 | |
N05C-Hypnotics and sedatives | | | | | | | | 2.9 | |
N06A-Antidepressants | | | | | | | | 122.2 | |
R-Respiratory system | | | | | | | | 33.4 | |
R03-Drugs for obstructive airway diseases | | | | | | | | 33.1 | |
Total pharmaceutical sales | Total pharmaceutical sales | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
A-Alimentary tract and metabolism | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |
A02A-Antacids | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |
A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD) | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |
A10-Drugs used in diabetes | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |
B-Blood and blood forming organs | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |
C-Cardiovascular system | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |
C01A-Cardiac glycosides | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |
C01B-Antiarrhythmics, Class I and III | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |
C02-Antihypertensives | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |
C03-Diuretics | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |
C07-Beta blocking agents | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |
C08-Calcium channel blockers | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |
C09-Agents acting on the Renin-Angiotensin system | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |
C10-Lipid modifying agents | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |
G-Genito urinary system and sex hormones | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |
G03-Sex hormones and modulators of the genital system | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |
H-Systemic hormonal preparations, excluding sex hormones and insulins | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |
J-Antiinfectives for systemic use | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |
J01-Antibacterials for systemic use | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |
M-Musculo-skeletal system | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |
M01A-Antiinflammatory and antirheumatic products non-steroids | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |
N-Nervous system | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |
N02-Analgesics | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |
N05B-Anxiolytics | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |
N05C-Hypnotics and sedatives | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |
N06A-Antidepressants | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |
R-Respiratory system | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |
R03-Drugs for obstructive airway diseases | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |
Products not elsewhere classified | Million of national currency units | | | | | | | | | |
Million US$ at exchange rate | | | | | | | | | |
Million US$, purchasing power parity | | | | | | | | | |
/capita, US$ exchange rate | | | | | | | | | |
/capita, US$ purchasing power parity | | | | | | | | | |
% of total sales | | | | | | | | | |